Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
This study will compare atomoxetine to placebo when taken with current standard Alzheimer's
Disease medications. The treatment will take approximately 6 months and it is hypothesized
atomoxetine will significantly improve cognitive performance as compared to placebo.